DrugPatentWatch Database Preview
Almirall Company Profile
» See Plans and Pricing
What is the competitive landscape for ALMIRALL, and what generic alternatives to ALMIRALL drugs are available?
ALMIRALL has fifteen approved drugs.
There are thirteen US patents protecting ALMIRALL drugs.
There are one hundred and sixty-four patent family members on ALMIRALL drugs in thirty-nine countries and seventeen supplementary protection certificates in eleven countries.
Summary for Almirall
| International Patents: | 164 |
| US Patents: | 13 |
| Tradenames: | 14 |
| Ingredients: | 12 |
| NDAs: | 15 |
Drugs and US Patents for Almirall
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Almirall | ACZONE | dapsone | GEL;TOPICAL | 207154-001 | Feb 24, 2016 | RX | Yes | Yes | 9,517,219 | Start Trial | Start Trial | ||||
| Almirall | VELTIN | clindamycin phosphate; tretinoin | GEL;TOPICAL | 050803-001 | Jul 16, 2010 | BX | RX | Yes | Yes | Start Trial | Start Trial | ||||
| Almirall | SEYSARA | sarecycline hydrochloride | TABLET;ORAL | 209521-003 | Oct 1, 2018 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Almirall | CORDRAN SP | flurandrenolide | CREAM;TOPICAL | 012806-002 | Approved Prior to Jan 1, 1982 | AT | RX | Yes | Yes | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Almirall
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Almirall | CORDRAN | flurandrenolide | TAPE;TOPICAL | 016455-001 | Approved Prior to Jan 1, 1982 | 3,632,740 | Start Trial |
| Almirall | VERDESO | desonide | AEROSOL, FOAM;TOPICAL | 021978-001 | Sep 19, 2006 | 6,730,288 | Start Trial |
| Almirall | SOLAGE | mequinol; tretinoin | SOLUTION;TOPICAL | 020922-001 | Dec 10, 1999 | 5,470,567 | Start Trial |
| Almirall | VELTIN | clindamycin phosphate; tretinoin | GEL;TOPICAL | 050803-001 | Jul 16, 2010 | 5,690,923 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ALMIRALL drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Gel | 7.5% | ➤ Subscribe | 2017-02-13 |
International Patents for Almirall Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Netherlands | 300304 | Start Trial |
| Australia | 2013348247 | Start Trial |
| Russian Federation | 2270002 | Start Trial |
| European Patent Office | 2455367 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Almirall Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1028961 | 306 | Finland | Start Trial | |
| 1304992 | 122013000081 | Germany | Start Trial | PRODUCT NAME: CLINDAMYCIN (ALS CLINDAMYCIN-PHOSPHAT) UND TRETINOIN; NAT. REGISTRATION NO/DATE: 85210.00.00 20130611; FIRST REGISTRATION: IRLAND PA1332/043/001 20130322 |
| 1028961 | 07C0057 | France | Start Trial | PRODUCT NAME: RETAPAMULIN; REGISTRATION NO/DATE IN FRANCE: EU/1/07/390/001 DU 20070524; REGISTRATION NO/DATE AT EEC: EU/1/07/390/001 DU 20070524 |
| 1304992 | 2013/044 | Ireland | Start Trial | PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
